The Nobel Prize for Chemistry 2004 - Ubiquitin: The everywhere protein receives the ultimate accolade!

EBR - European Biopharmaceutical Review

Volumn , Issue SUMMER, 2005, Pages

  Mayer, R John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOCHEMISTRY; DEMENTIA; DRUG MECHANISM; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LEWY BODY; MULTIPLE MYELOMA; MUSCLE ATROPHY; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

EID: 22944447147     PISSN: 1364369X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schoenheimer R, The Dynamic State of Body Constituents, Harvard University Press, 1942
2. Simpson MV, The release of labeled amino acids from proteins in liver slices, Journal of Biological Chemistry 201, pp143-154, 1953
3. Wilkinson KD, Urban MK and Haas AL, Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes, J Biol Chem 255, pp7,529-7,532, 1980
4. Glickman MH and Ciechanover A, The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction, Physiol Rev 82, pp373-428, 2002
5. Hough R, Pratt G and Rechsteiner M, Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates, J Biol Chem 261, pp2,400-2,408, 1986
6. Waxman L, Fagan JM and Goldberg AL, Demonstration of two distinct molecular weight proteases in rabbit reticulocytes, one of which degrades ubiquitin conjugates, J Biol Chem 262: pp2,451-2,457, 1987
7. DeMartino GN, Moomaw CR, Zagnitko OP, Proske RJ, Chu-Ping M, Afendis SJ, Swaffield JC and Slaughter CA, PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family, J Biol Chem 269, pp20,878-20,884, 1994
8. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, and Finley D, A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3, Cell 94, pp615-623, 1998
9. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F and Wittinghofer A, The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue, Nature 375, pp554-560, 1995
10. Mayer RJ, Landon M and Layfield R, Ubiquitin superfolds: intrinsic and attachable regulators of cellular activities? Fold Des 3, R97-99, 1998
11. Hicke L, Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels, Trends Cell Biol 9, pp107-112, 1999
12. Rodriguez MS, Desterro JM, Lain S, Lane DP and Hay RT, Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation, Mol Cell Biol 20, pp8,458-8,467, 2000
13. Xirodimas DP, Saville MK, Bourdon JC, Hay RT and Lane DP, Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity, Cell 118, pp83-97, 2004
14. Verma R, Aravind L, Oania R, McDonald WH, Yates JR, 3rd, Koonin EV and Deshaies R.J, (2002), Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome, Science 298, pp115-611, 2005
15. Lowe J, Mayer RJ and Landon M, Ubiquitin in neurodegenerative diseases, Brain Pathol 3, pp55-65, 1993
16. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ and Layfield R, Inhibition of the ubiquitin-proteasome system in Alzheimer's disease, Proc Natl Acad Sci U S A 97, pp9,902-9,906, 2000
17. Mizuno Y, Hattori N, Mori H, Suzuki T and Tanaka K, Parkin and Parkinson's disease, Curr Opin Neurol,14 pp477-482, 2001
18. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T et al, The ubiquitin pathway in Parkinson's disease, Nature 395, pp451-452, 1998
19. Pagano M, Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis, Molecular Cell 14, pp414-416, 1995
20. Ravid T and Hochstrasser M, NF-kB signalling: flipping the switch with polyubiquitin chains, Current Biology 14, R898-R900, 1995
21. Wray CJ, Mammen JM and Hasselgren PO, Catabolic response to stress and potential benefits of nutrition support, Nutrition 18, pp971-977, 2002
22. Lee SW, Dai G, Hu Z, Wang X, Du J and Mitch WE, Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase, J Am Soc Nephrol 15, pp1,537-1,545, 2004
23. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B et al, The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover, Science 308, pp1,599-1,603, 2005
24. Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS, and Layfield R, Loss of ubiquitin-binding associated with Paget's disease of bone, p62 (SQSTM1) mutations, Journal of Bone and Mineral Research 20, pp619-624, 2005
25. Veiga E and Cossart P, Ubiquitination of intracellular bacteria: a new bacteria-sensing system? Trends Cell Biol 15, pp2-5, 2005
26. Atir-Lande A, Gildor T and Kornitzer D, Role for the SCFCDC4 ubiquitin ligase in candida albicans morphogenesis, Mol Biol Cell 16, pp2,772-2,785 2005
27. Goy A, and Gilles F, Update on the proteasome inhibitor bortezomib in hematologic malignancies, Clin Lymphoma 4, pp230-237, 2004
28. McNaught KSP, Perl DP, Brownwnell AL and Olanow CW, Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's Disease, Annals of Neurology 56, pp149-162, 2004
29. Dawson S, Mee M, Apcher S, Higashitsuji H, Baker R, Uhle S, Dubiel W, Fujita J, and Mayer R.J, Gankyrin: an ankyrin-repeat oncoprotein interacts with CDK4 kinase and the S6 ATPase of the 26S proteasome. Journal of Biological Chemistry 277, pp10,893-10,902, 2002
30. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, and Fujita J, Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas, Nat Med 6, pp96-99, 2000
31. Verma R et al, Ubistatins inhibit proteasome-dependant degradation by binding the ubiquitin chain, Science 306: pp117-120, 2004